Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES

ACCRUED EXPENSES

3 Months Ended

Mar. 31, 2024

ACCRUED EXPENSES

ACCRUED EXPENSES

NOTE 9. ACCRUED EXPENSES

Accrued expenses consisted of the following:


		March 31,			December 31,
($’s in thousands)		2024			2023
Accrued expenses:
Accrued coupons and rebates		$	7,169		$	9,987
Return reserve			2,806			4,077
Accrued compensation			3,599			3,374
Accrued royalties payable			1,382			2,015
Accrued legal, accounting and tax			335			185
Accrued research and development			3,034			20
Accrued inventory			581			352
Accrued iPledge program			587			174
Other			540			166
Total accrued expenses		$	20,033		$	20,350